We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Diagnosing Asthma with an Electronic Nose

By HospiMedica staff writers
Posted on 05 Jun 2007
An electronic nose could be used in the future to diagnose asthma. More...


Scientists presented a preliminary study of the device at the American Thoracic Society 2007 International Conference, on Monday, May 21, 2007, in San Francisco (CA, USA). The device contains chemical vapor sensors that react to the presence of volatile organic compounds (VOCs) in a person's exhaled breath. A person's breath contains a mixture of thousands of VOCs that may be used as markers of lung disease, said Dr. Silvano Dragonieri, of Leiden University Medical Center (The Netherlands).

The electronic nose is a newer version of a sensor that has been used in the food, wine, and perfume industries. It is also being used to counter terror, detecting explosives or toxic chemicals in the air.

An electronic nose responds to a given odor by generating a pattern, or smell print, which is analyzed and compared with stored patterns. An electronic nose has been developed that can diagnose respiratory infections such as pneumonia by comparing smell prints from the breath of a sick patient with those of patients with standardized readings. It is also being studied as a diagnostic tool for lung cancer.

In the new study, the researchers compared the smell prints of 20 people with diagnosed asthma (half with severe asthma and half with mild disease) and 20 individuals without asthma to see if the electronic nose could classify them as asthmatic or non-asthmatic. The subjects breathed into a facemask attached to a bag connected to the electronic nose.

The nose was able to detect which smell prints came from people with asthma, but was less accurate in classifying the severity of an individual's asthma. The asthmatic patients in this study already had been diagnosed with asthma, said Dr. Dragonieri The next step is to see whether the nose can diagnose new patients with asthma. It is still a futuristic device--one day different electronic noses may be built to detect specific diseases.


Related Links:
Leiden University Medical Center

Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology System
Riviera SPV AT
Imaging Table
Stille imagiQ2
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.